The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
Global capabilities - Insights
Check out how Mayo Clinic Laboratories optimized global capabilities facilitate individualized solutions that ensure international clients receive expeditious, accurate answers.
Pathways Case Studies: October 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for October include the following sub-specialties Breast Pathology, Gynecological...
CREDIT OFFERED PROGRAM EVENT TITLE CREDIT HOURS GENERAL CERT. PACE STATE OF CA STATE OF FL AMA AAFP MOC NURSING RECORD OF VIEWING CASE STUDIES Mayo Clinic Pathways Case Studies N/A CONFERENCES Bleeding and Thrombosing Diseases...
Testing for Streptococcus pneumoniae Antibodies - Insights
In this month's "Hot Topic," Melissa Snyder, Ph.D., identifies the clinical application of testing for Streptococcus pneumoniae polysaccharide antibodies and describes the tests available for measuring these antibodies.
High-Resolution Targeted Benzodiazepine Screen - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic’s targeted benzodiazepine assay and discusses the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine...
Pathways Case Studies: July 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Breast Pathology, Cytopathology &...
Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, discusses the most commonly cited Occupational Safety and Health Administration inspection findings for medical and diagnostic laboratories.
MCL @Work: Ben Levno - Insights
As a senior product manager for Mayo Clinic Laboratories, Ben Levno supports the neurology segment of specialty testing. While Mayo Clinic physicians have access to our world-renowned neurology testing to diagnose and care for patients,...
The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.
Find out how our unique tests, methodologies, and reference ranges provide fast, accurate results for complex pediatric gastroenterology conditions.
Inflammatory Bowel Disease - Mayo Clinic Laboratories
Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...
Carbohydrate metabolism - Insights
Learn more about how Mayo Clinic Laboratories testing for carbohydrate metabolism can identify genetic variants and confirm diagnosis of these complex conditions.
Learn more about how Mayo Clinic Laboratories helps hospital laboratories reduce costs and grow revenue.
At BioPharma Diagnostics, we are inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — from consulting through discovery to...
A new path forward: Hussein - Insights
For a young child diagnosed with inflammatory bowel disease, an unexpected turn of events led by results of a Mayo Clinic Laboratories test freed him and his family from the bonds of frequent medical visits and expensive treatment, and...
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
Future Direction of Lab Medicine - Insights
Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.
Groundbreaking collaborations - Insights
Together with hospitals, biopharma companies, and healthcare organizations around the globe, we are clearing the path for new technologies that will improve patient care.
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
How the COVID-19 pandemic has increased public knowledge of lab testing - Insights
While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the...
MML Prenatal Testing Brochure - MC2775-111
MML Prenatal Testing Brochure - PRENATAL TESTING COMPREHENSIVE SCREENING DIAGNOSTIC TESTING FETAL ABNORMALITIES WOMEN HEALTH CLINIC PRENATAL TESTING
MCL Infectious Specimen Shipping Guidelines MC1235168
MCL Infectious Specimen Shipping Guidelines Infectious Specimen Shipping Guidelines Shipper Responsibilities test send area considered shipper send specimens
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Surprises in Coagulation Testing - Insights
In this “Hot Topic,” William Nichols, M.D., presents a case study that demonstrates how pre- and postanalytic variables of the patient and blood samples can have confounding effects on the laboratory evaluation of coagulation disorders.
Robin Patel, M.D., Elected to 2-Year Term on ASM Board of Directors - Insights
Robin Patel, M.D., Chair of the Division of Clinical Microbiology and a Consultant in the Clinical Microbiology and Infectious Diseases Laboratories at Mayo Clinic, has been elected to serve a two-year term on the American Society for...
Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights
Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.
Pathways Case Studies: March 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cytopathology,...
Antifungal Drug Susceptibility Testing of Yeast: A Primer for Beginners - Insights
In this month’s “Hot Topic,” Nancy Wengenack, Ph.D., discusses susceptibility testing of yeast for those who are considering performing it in their laboratory, perhaps for the first time, or for those who choose to send their yeast isolates...
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
CPT codes and LOINC update: November 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of November
celiac_disease_diagnostic_testing_algorithm.pdf
08/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Celiac Disease Diagnostic Testing Algorithm Testing for selective IgA deficiency IGA / Immunoglobulin A (IgA), Serum TTGA / Tissue...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
December 2022 - Renal - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal Pathology.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...
Hospitals and health systems - Insights
Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.
Commercial laboratories - Insights
Mayo Clinic Laboratories is a one stop laboratory solution for commercial laboratories, offering the industry’s most comprehensive test menu, 24/7 customer service support and streamlined logistics to help clients meet their business goals.
Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...
New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights
To coincide with American Red Cross recommendations, the Mayo Clinic Blood Donor Program has redefined eligibility guidelines for donors who have had a history of previous cancer diagnoses.
On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease predictions for 2017.
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
search - Mayo Clinic Laboratories
Search Results Test Catalog...